Skip to main content

Table 2 PEDro scale for clinical trials

From: Utilization of wearable technology to assess gait and mobility post-stroke: a systematic review

Author

Eligibility criteria specifieda

Subjects randomly allocated to groups

Allocation was concealed

Groups were similar at baseline

Blinding of all subjects

Blinding of all therapists who provided therapy

Blinding of all assessors

Measures at least 1 key outcome obtained from > 85% of subjects

All subjects received allocated tx or control or “intent to treat” analysis

Results of between group statistical comparisons are reported

Study provides both point measures and measures of variability

Total

Dorsch et al. [51]

1

1

1

1

0

0

1

0

0

1

1

6

Mansfield et al. [36]

1

1

1

1

0

0

1

1

0

1

1

7

English et al. [52]

1

1

1

1

1

0

1

1

1

1

1

9

Givon et al. [53]

1

1

1

1

0

0

1

1

1

1

1

8

Danks et al. [54]

1

1

1

1

0

0

1

1

1

1

1

8

Kanai et al. [55]

1

1

1

1

1

0

0

1

1

1

1

8

Paul et al. [60]

1

1

0

1

0

0

0

1

1

1

1

6

  1. 1 = yes; 0 = no
  2. tx treatment
  3. aDoes not contribute points to the total score